التفاصيل البيبلوغرافية
| العنوان: |
Ixazomib Plus Lenalidomide-Dexamethasone (IRd) in Relapsed/Refractory Multiple Myeloma (MM) Patients (Pts) - Effectiveness in Routine Clinical Practice Is Similar to the Efficacy in the Phase 3 Tourmaline-MM1 Trial: A Pooled Analysis from the Insight MM Observational Study and the Czech Registry of Monoclonal Gammopathies (RMG) |
| المؤلفون: |
Hajek, R, Terpos, E, Lee, HC, Chari, A, Costello, CL, Puig, N, Leleu, X, Berdeja, JG, Davies, FE, Weisel, K, Usmani, SZ, Hungria, VTM, Boccadoro, M, Rifkin, RM, Zonder, JA, Cook, G, Brožová, L, Bařinová, M, Ren, K, Cacioppo, R, Skacel, T, Stull, DM, Maisnar, V |
| بيانات النشر: |
American Society of Hematology |
| سنة النشر: |
2018 |
| المجموعة: |
White Rose Research Online (Universities of Leeds, Sheffield & York) |
| نوع الوثيقة: |
report |
| اللغة: |
unknown |
| Relation: |
Hajek, R, Terpos, E, Lee, HC et al. (20 more authors) (2018) Ixazomib Plus Lenalidomide-Dexamethasone (IRd) in Relapsed/Refractory Multiple Myeloma (MM) Patients (Pts) - Effectiveness in Routine Clinical Practice Is Similar to the Efficacy in the Phase 3 Tourmaline-MM1 Trial: A Pooled Analysis from the Insight MM Observational Study and the Czech Registry of Monoclonal Gammopathies (RMG). In: Blood. ASH 2018 – 60th American Society of Hematology Annual Meeting and Exposition, 01-04 Dec 2018, San Diego, CA. American Society of Hematology . |
| الاتاحة: |
https://eprints.whiterose.ac.uk/157103/ |
| رقم الانضمام: |
edsbas.E99E1EA8 |
| قاعدة البيانات: |
BASE |